Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;41(1):43-50.

Potassium-Binding Agents for the Clinical Management of Hyperkalemia

Martin Chaitman, Deepali Dixit, Mary Barna Bridgeman

Potassium-Binding Agents for the Clinical Management of Hyperkalemia

Martin Chaitman et al. P T. 2016 Jan.

Abstract

Use of sodium polystyrene sulfonate (SPS) dominates the long-term treatment of hyperkalemia, but two new agents, sodium zirconium cyclosilicate and the recently FDA-approved patiromer, may offer potential advantages compared with SPS.

Keywords: hyperkalemia; patiromer; sodium polystyrene sulfonate; sodium zirconium cyclosilicate.

PubMed Disclaimer

References

    1. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Part 10.1: life-threatening electrolyte abnormalities. Circulation. 2005;112:IV-121–IV-125. - PubMed
    1. Mandal AK. Hypokalemia and hyperkalemia. Med Clin North Am. 1997;81:611–139. - PubMed
    1. Kraft MD, Btaiche IF, Sacks GS, Kudsk KA. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health Syst Pharm. 2005;62:1663–1682. - PubMed
    1. Acker CG, Johnson JP, Palevsky PM, Greenberg A. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med. 1998;158:917–924. - PubMed
    1. Williams ME. Hyperkalemia. Crit Care Clin. 1991;7:155–174. - PubMed

LinkOut - more resources